A spat erupted this week as Washington and Zambia in Africa failed to seal a strategic health‑aid package. The United States offered billions in medical assistance, but outgoing ambassador Michael Gonzales accused Zambia’s government of graft, prompting foreign minister Mulambo Haimbe to charge the deal was tied to access to the nation’s critical minerals. The row underscores the Trump administration’s push to replace USAID with an “America First” model.

Gonzales announced a $50 million reduction in annual U.S. medicine aid to Zambia, citing “systematic theft” of donated drugs. He argued that aid should not subsidise corrupt officials and called for tighter accountability. Zambia’s foreign ministry replied with a six‑page protest, saying the ambassador’s claims distorted the negotiations and that linking health support to mining access was unacceptable.

Analysts warn the standoff could drive Zambia closer to China, which already dominates its copper, lithium and cobalt sectors. If the health‑funding deal collapses, American companies lose a potential foothold in a mineral‑rich market, while U.S. aid credibility suffers. The episode illustrates how politicised assistance can jeopardise both humanitarian goals and strategic resource access.